Amgen to spend $100M to build new vial filling line at Dublin site: report jkeenan Tue, 12/21/2021 – 09:47 More: Amgen to spend 0M to build new vial filling line at Dublin site: report Source: fierce
read moreTurkish biotech bags $12M for targeted delivery of cancer drugs ntaylor Tue, 12/21/2021 – 09:28 More: Turkish biotech bags M for targeted delivery of cancer drugs Source: fierce
read moreWith approval, Saphnelo would be the first available treatment for systematic lupus erythematosus in Europe in over ten years. More: CHMP recommend Saphnelo for systematic lupus erythematosus Source: News
read moreThe DETERMINE trial aims to discover whether existing ‘licensed’ drugs could also benefit patients with rare cancer types that the drug is not currently licensed for. More: Cancer researchers across the UK partner in new trial to find drugs for
read moreIntra-Cellular scores another FDA nod for Caplyta, this time for bipolar disorder kdunleavy Mon, 12/20/2021 – 15:54 More: Intra-Cellular scores another FDA nod for Caplyta, this time for bipolar disorder Source: fierce
read moreBluebird bio hits FDA clinical hold—again—for gene therapy in sickle cell disease aliu Mon, 12/20/2021 – 10:28 More: Bluebird bio hits FDA clinical hold—again—for gene therapy in sickle cell disease Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals